A coordination meeting between the Common Management Unit (CMU) and the National Pharmacovigilance Centre, Drug Regulatory Authority of Pakistan (DRAP) was held on July 29, 2026, to discuss strengthening pharmacovigilance activities across the National TB, HIV/AIDS, and Malaria programmes. The meeting focused on improving adverse drug reaction (ADR) reporting, strengthening monitoring and follow-up mechanisms, and expanding the implementation of pharmacovigilance activities across all three programmes.
